Advances in Hematological Malignancies
Recent decades have witnessed remarkable advancements in the domain of hematological malignancies. Novel treatment modalities such as targeted agents, immunotherapies, and therapy are transforming the outlook for patients with blood cancers. Clinical trials continue to explore these innovative strat